ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AMP Amphion Innovations Plc

0.15
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Amphion Innovations Plc LSE:AMP London Ordinary Share GB00B0DJNP99 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.15 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Amphion Innovations PLC Director/PDMR Shareholding (9668S)

13/11/2013 4:33pm

UK Regulatory


Amphion Innovations (LSE:AMP)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Amphion Innovations Charts.

TIDMAMP

RNS Number : 9668S

Amphion Innovations PLC

13 November 2013

Directors' Dealings

Directors Receive Shares in Lieu of Fees

London and New York, 13 November 2013- Amphion Innovations plc (the "Company") (LSE: AMP), the developer of medical and technology businesses, announces that the Company has today issued 663,821 ordinary shares, representing 0.45% of the enlarged issued share capital, to certain of its Board members as their directors' fees for the fourth quarter of 2012 and the first three quarters of 2013, priced at 4.175 pence, being the average of the closing mid-market price for the five days leading up to the market close on 12 November 2013.Following this issue, the directors' shareholdings in the Company are as follows:

 
Director            Number of New Shares  Total Shareholding  Percentage of voting rights 
 
R. James Macaleer   501,321               24,480,266          16.666% 
Gerard Moufflet     162,500               862,500              0.587% 
 

Director, Anthony Henfrey waived his fees for the fourth quarter of 2012 as well as for the first three quarters of 2013.

Admission of the 663,821 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected on 19 November 2013. Following this allotment the total issued share capital of the Company will increase to 146,884,071 ordinary shares with each share holding one voting right.

For further information please contact

Amphion Innovations

Charlie Morgan

+1 212 210 6224

Novella Communications

Tim Robertson / Ben Heath

+44 020 3151 7008

Panmure Gordon Limited

Freddy Crossley / Grishma Patel (Corporate Finance)

Adam Pollock (Corporate Broking)

+44 020 7886 2500

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

On the web: www.amphionplc.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQXLFFXFFXFBL

1 Year Amphion Innovations Chart

1 Year Amphion Innovations Chart

1 Month Amphion Innovations Chart

1 Month Amphion Innovations Chart

Your Recent History

Delayed Upgrade Clock